BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1979001)

  • 1. Effects of dopamine D-1 and D-2 antagonists on decision making by rats: no reversal of neuroleptic-induced attenuation by scopolamine.
    Ljungberg T; Enquist M
    J Neural Transm Gen Sect; 1990; 82(3):167-79. PubMed ID: 1979001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the dopamine D-1 antagonist SCH 23390 on water intake, water-rewarded operant responding and apomorphine-induced decrease of water intake in rats.
    Ljungberg T
    Pharmacol Biochem Behav; 1989 Jul; 33(3):709-12. PubMed ID: 2685829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential attenuation of water intake and water-rewarded operant responding by repeated administration of haloperidol and SCH 23390 in the rat.
    Ljungberg T
    Pharmacol Biochem Behav; 1990 Jan; 35(1):111-5. PubMed ID: 2179968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P; Friedman E
    Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scopolamine reverses haloperidol-attenuated lever-pressing for water but not haloperidol-attenuated water intake in the rat.
    Ljungberg T
    Pharmacol Biochem Behav; 1988 Jan; 29(1):205-8. PubMed ID: 3353427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine, SCH 23390 and alpha-flupenthixol but not haloperidol attenuate acute phencyclidine-induced disruption of conditional discrimination performance.
    Dunn MJ; Killcross S
    Psychopharmacology (Berl); 2007 Mar; 190(4):403-14. PubMed ID: 17237918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390.
    Hjorth S; Carlsson A
    J Neural Transm; 1988; 72(2):83-97. PubMed ID: 2968439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D-2 antagonists reverse apomorphine-induced decreased water intake in the rat: prediction of antipsychotic drugs with few extrapyramidal side-effects?
    Ljungberg T
    J Neural Transm; 1989; 76(2):79-90. PubMed ID: 2565360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalepsy induced by SCH 23390 in rats.
    Morelli M; Di Chiara G
    Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological differentiation of dopamine D-1 and D-2 antagonists after single and repeated administration.
    Christensen AV; Arnt J; Svendsen O
    Psychopharmacology Suppl; 1985; 2():182-90. PubMed ID: 2860659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
    Duarte C; Biala G; Le Bihan C; Hamon M; ThiƩbot MH
    Psychopharmacology (Berl); 2003 Feb; 166(1):19-32. PubMed ID: 12525958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of dopamine D-1 and D-2 receptors in diazepam-induced hyperphagia in rats.
    Naruse T; Amano H; Koizumi Y
    Fundam Clin Pharmacol; 1991; 5(8):677-93. PubMed ID: 1838347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective alleviation of compulsive lever-pressing in rats by D1, but not D2, blockade: possible implications for the involvement of D1 receptors in obsessive-compulsive disorder.
    Joel D; Doljansky J
    Neuropsychopharmacology; 2003 Jan; 28(1):77-85. PubMed ID: 12496943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
    Imperato A; Di Chiara G
    Eur J Pharmacol; 1988 Nov; 156(3):385-93. PubMed ID: 2905668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of drinking by naltrexone in the rat: interaction with the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpiride.
    Ukai M; Nakayama S; Kameyama T
    Pharmacol Biochem Behav; 1989 Mar; 32(3):651-5. PubMed ID: 2662222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpiride on saline acceptance-rejection in water-deprived rats.
    Gilbert DB; Cooper SJ
    Pharmacol Biochem Behav; 1987 Apr; 26(4):687-91. PubMed ID: 3299396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats.
    Levin ED
    Behav Neural Biol; 1988 Sep; 50(2):240-5. PubMed ID: 2906537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.
    Obuchowicz E
    Neuropeptides; 1996 Oct; 30(5):471-8. PubMed ID: 8923510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons.
    Goldstein JM; Litwin LC; Sutton EB; Malick JB
    Life Sci; 1987 Mar; 40(11):1039-44. PubMed ID: 2950291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat.
    Dall'Olio R; Roncada P; Vaccheri A; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1989; 98(3):342-6. PubMed ID: 2568655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.